Gammagard and Infusion site urticaria - a phase IV clinical study of FDA data

Summary:

Infusion site urticaria is reported as a side effect among people who take Gammagard (immune globulin), especially for people who are female, 50-59 old, also take Montelukast Sodium, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Infusion site urticaria when taking Gammagard. It is created by eHealthMe based on reports of 8,933 people who have side effects when taking Gammagard from the FDA, and is updated regularly.

What is Gammagard?

Gammagard has active ingredients of immune globulin. eHealthMe is studying from 8,947 Gammagard users. Check the latest studies of Gammagard.

What is Infusion site urticaria?

Infusion site urticaria (rash of round, red welts on the skin at infusion site) is found to be associated with 180 drugs and 89 conditions by eHealthMe. Check the latest studies of Infusion site urticaria.

On Jul, 06, 2026

8,933 people reported to have side effects when taking Gammagard.
Among them, 26 people (0.29%) have Infusion site urticaria.

Could Gammagard cause Infusion site urticaria?

Among these 26 people:

What is the gender of people who have Infusion site urticaria when taking Gammagard? *

female: 88.46 %
male: 11.54 %

What is the age of people who have Infusion site urticaria when taking Gammagard? *

What are other drugs people take besides Gammagard? *

Acetaminophen: 9 people, 34.62%
Epinephrine: 9 people, 34.62%
Fasenra: 9 people, 34.62%
Montelukast Sodium: 9 people, 34.62%
Benadryl: 8 people, 30.77%
Calcium: 8 people, 30.77%
Fluticasone Propionate: 8 people, 30.77%
Pantoprazole: 8 people, 30.77%
Ofloxacin: 7 people, 26.92%
Promethazine: 7 people, 26.92%

What are other side effects people have besides Infusion site urticaria? *

Infusion Site Pruritus (severe itching at infusion site): 11 people, 42.31%
Infusion Site Rash: 10 people, 38.46%
Infusion Site Swelling: 9 people, 34.62%
Cellulitis (infection under the skin): 9 people, 34.62%
Malaise (a feeling of general discomfort or uneasiness): 9 people, 34.62%
Seasonal Allergy (allergic condition due to certain season): 8 people, 30.77%
Nausea And Vomiting: 8 people, 30.77%
Nausea (feeling of having an urge to vomit): 8 people, 30.77%
Infusion Site Pain: 8 people, 30.77%
Dehydration (dryness resulting from the removal of water): 8 people, 30.77%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 16 people, 61.54%
Primary Immunodeficiency Syndrome: 7 people, 26.92%
Asthma: 6 people, 23.08%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 3 people, 11.54%
Immunodeficiency: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gammagard and have Infusion site urticaria?

- Check whether Infusion site urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gammagard:

Gammagard (8,947 reports)

Browse all side effects of Gammagard:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site urticaria:

Infusion site urticaria (180 drugs)

Browse all the conditions that are associated with Infusion site urticaria:

Infusion site urticaria (89 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on immune globulin (the active ingredients of Gammagard) and Gammagard (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.